New vaccine shows promise /
Series: Nursing 2015. 45 : 2, page 13 Publication details: February 2015.ISSN:- 0360-4039
Current library | Call number | Status | Date due | Barcode |
---|---|---|---|---|
Manila Tytana Colleges Library REFERENCE SECTION | Bound (Browse shelf(Opens below)) | Not For Loan |
Healthcare providers were taken by surprise by the 2014 Ebola virus disease (EVD) epidemic in West Africa. As part of an international effort to develop a preventive vaccine: one group of researchers conducted a phase 1, dose escalation open-label trial of a replication-defective recombinant chimpanzee adenovirus type 3-vectored ebolavirus vaccine (cAd3-EBO). In this trial, which was designed to test the vaccine's safety and immunogenicity, 20 healthy adults received the vaccine I.M.
Nursing
There are no comments on this title.